8-hydroxymianserin: metabolite of mianserin; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 162817 |
| SCHEMBL ID | 2739028 |
| MeSH ID | M0093601 |
| Synonym |
|---|
| 8-hydroxymianserin |
| 57257-81-5 |
| 2h-dibenzo(c,f)pyrazino(1,2-a)azepin-8-ol, 1,2,3,4,10,14b-hexahydro-2-methyl- |
| FT-0669860 |
| unii-cd0r9qb6hd |
| cd0r9qb6hd , |
| 8-hydroxy mianserin |
| SCHEMBL2739028 |
| 8-hydroxy ms |
| dibenzo(c,f)pyrazino(1,2-a)azepin-8-ol, 1,2,3,4,10,14b-hexahydro-2-methyl- |
| 5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaen-17-ol |
| DTXSID30972746 |
| 2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepin-8-ol |
| Q27275402 |
| 5-methyl-2,5-diazatetracyclo[13.4.0.0?,?.0?,??]nonadeca-1(15),8,10,12,16,18-hexaen-17-ol |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.21) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (12.50%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||